Submission of requests for joint scientific consultations
Article 3
1. Any time during the request period published pursuant to Article 17(3) of Regulation (EU) 2021/2282, a health technology developer may submit a request for a joint scientific consultation on the medical device or in vitro diagnostic medical device through the IT platform referred to in Article 30 of that Regulation (‘the HTA IT platform’). The request shall follow the template established by the Coordination Group pursuant to Article 21, point (a), of Regulation (EU) 2021/2282. 2. When submitting the request for joint scientific consultation on a medical device, the health technology developer shall indicate whether it is requesting the expert panel consultation to be carried out in parallel.